GEn1E Lifesciences is a clinical-stage biotechnology company that develops small molecule therapeutics for inflammatory and rare diseases. Its pipeline includes intravenous and oral therapies, with one candidate in Phase 2 clinical trials for Acute Respiratory Distress Syndrome. The company collaborates with pharmaceutical companies, healthcare providers, and government agencies.